Generic Name: N/A
Drug Class: NAFLD/NASH Medications
Company: Gilead Sciences
Approval Status: Experimental
Generic Version Available: No
Experimental Code: GS-9674
General Info
Cilofexor is a farnesoid X receptor (FXR) agonist in Phase 2 clinical trials for treatment of non-alcoholic steatohepatitis (NASH).
Dosage
Dosing Info: N/A
Side Effects
N/A
Last Reviewed: May 2, 2019
